A clinical trial to study the effects of Yograj Rasayan in patients with Anaemia.
Phase 3
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecifiedHealth Condition 2: D539- Nutritional anemia, unspecifiedHealth Condition 3: D519- Vitamin B12 deficiency anemia, unspecified
- Registration Number
- CTRI/2020/03/023873
- Lead Sponsor
- Dr Megha Choudhary
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patientâ??s age between 16 to 60 years, presenting signs and symptoms of Pandu Roga (Anaemia).
2. Patient having Hb% <11 gm/dL in female and <13 gm/dL in male.
3. Patient or its attendant is able and willing to provide written informed consent.
Exclusion Criteria
1. Patient suffering with severe anaemia, having Hb% <8 gm/dL in both male and female.
2. Patient already taking treatment for Anaemia (Pandu Roga).
3. Pregnant and lactating women.
4. Patients of Sickle Cell Anaemia and Thalassemia.
5. Patient having Pandu Roga as complication or having other systemic and/or local disease.
6. Patient who will have ADR (Adverse Drug Reaction) during the course of the study will be discontinued from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of Yograj Rasayan in the treatment of Anaemia.Timepoint: 30 days
- Secondary Outcome Measures
Name Time Method To categorize Anaemia on the basis of RDW (Red blood cell Distribution Width).Timepoint: 1 year;To correlate sub. types of Pandu Roga on the basis of RDW (Red blood cell Distribution Width).Timepoint: 1 year;To study Pandu Roga and its diagnosis in detail according to Ayurvedic classics and modern medical science.Timepoint: 1 year